Navigation Links
Nation's #1 Respiratory Hospital Enters Agreement to Co-Promote IgE Blood Testing
Date:10/31/2008

- Partnership Underscores Role of Allergy Testing in Improving Asthma

Outcomes -

DENVER, Oct. 31 /PRNewswire/ -- National Jewish Health announced today that it has entered a co-promotion agreement with Phadia, US Inc. to build recognition of the important role allergy testing plays in the diagnosis and treatment of asthma and other respiratory diseases. Under the agreement, National Jewish Health will help create educational programs, activities and literature to promote to pulmonologists the value of understanding allergy in the diagnosis and management of patients with respiratory diseases. National Jewish will discuss available methodologies for in-office testing for allergies in these patients. Phadia currently has a product for such testing in the office, ImmunoCAP Rapid, which is currently under review by the United States Food and Drug Administration (FDA). Phadia anticipates FDA clearance by the end of the first quarter of 2009.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080711/DC27335LOGO)

"National Jewish Health is devoted to combating the uncontrolled asthma epidemic in the United States, and access in our clinics and regional sites to the latest technology will further accelerate our success," said David Tinkelman, MD, Vice President of Health Initiatives at National Jewish. "Our expertise will be invaluable in creating educational opportunities for this important part of the assessment of patients with respiratory diseases."

National Jewish will develop educational services and materials emphasizing the importance and utility of testing patients for allergy in the office setting for pulmonologists. Those services include many elements, but importantly a website for both consumers and physicians who can seek advice and assistance for treatment and avoidance options.

According to the American Academy of Allergy, Asthma and Immunology, approximately 23 million Americans have asthma and more than seven million of these are children, making it one of the most common chronic diseases of childhood. While the number of asthma-related deaths has declined in recent years, asthma remains the cause for nearly two million emergency room visits annually, resulting in a significant economic burden on our healthcare system.

National Jewish Health is known worldwide for treatment of patients with respiratory, immune and related disorders, and for groundbreaking medical research. For 11 consecutive years, U.S. News & World Report has ranked National Jewish the No. 1 respiratory hospital in the nation. National Jewish's Advanced Diagnostics Lab is the nation's leading immunology reference lab, featuring a comprehensive menu of respiratory, molecular, and companion diagnostic tests. More information can be found by visiting http://www.nationaljewish.org.

About Phadia

Phadia AB , headquartered in Uppsala, Sweden , is the world leader in in vitro IgE diagnostic research and product development. Its U.S. affiliate is in Portage, Michigan. More information can be found by visiting http://www.phadia.com


'/>"/>
SOURCE National Jewish Health
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Growing Number of U.S. Kids Not Getting Needed Vaccinations
2. Flu Vaccinations Begin on September 29 Maxim Health Systems to Provide 24,000 Flu Shot Clinics Nationwide
3. Whole Foods Market(R) Donates $25,000, for Midwest Farmers - Hoping to Match an Additional $10,000, via Customer Donations
4. New Report Says a Pandemic is Overdue, But Companies and Nations are ill Prepared to Cope With the Impact
5. Women Deliver Conference to Feature United Nations Leaders
6. New transfusion rules restrict donations from previously pregnant women
7. PA Governor Rendell Announces Latest Nominations and Appointments
8. Wide income gap linked to deaths in both rich and poor nations
9. Shareholder Proposals and Director Nominations Due November 5, 2007
10. United Animal Nations Offers Financial Assistance Grants of up to $500 to Help Southern California Fire Victims Obtain Vet Care, Temporary Boarding for Pets
11. First United Nations World Diabetes Day Unites Global Diabetes Community to Fight the Epidemic
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2017)... ... April 21, 2017 , ... The Patient Advocacy Community of The Beryl ... 2017 Ruth Ravich Patient Advocacy Award in recognition of her extraordinary contributions ... with the award at The Beryl Institute’s annual Patient Experience Conference on ...
(Date:4/21/2017)... (PRWEB) , ... April 21, 2017 , ... Alive ... people who wish to overcome their mental health struggles. The Alive team uses ... LeBouthillier says: “Our approach in dealing with a mental health struggle is based on ...
(Date:4/21/2017)... Ramon, CA (PRWEB) , ... April 21, 2017 , ... ... might not understand the estate planning process, or where to even begin. “Now more ... unresolved if you are to properly protect yourself and your family,” said attorney Lisa ...
(Date:4/21/2017)... ... April 21, 2017 , ... During April 21-23, Super-Sod will join the ... festival offers entertainment for everyone — from the avid gardener to the landscape admirer ... high quality event held in a grand venue, and we are certainly looking forward ...
(Date:4/21/2017)... ... April 21, 2017 , ... MiracleFeet announced today ... years to help end the disability caused by untreated clubfoot in low-income countries. ... Global Clubfoot Initiative to end disability caused by clubfoot worldwide. , ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... BOSTON , April 20, 2017   ZappRx, Inc ... the specialty drug prescribing process, today announced it closed $25 ... Fund, a venture capital firm based in Seattle ... Qiming Venture Partners . The Series B round included ... A round in 2014, and GV (formerly Google ...
(Date:4/20/2017)... 20, 2017 NeuroVive Pharmaceutical AB (Nasdaq ... positive preclinical results demonstrating anti-fibrotic effects with ... steatohepatitis (NASH), in an additional well-validated experimental ... has previously shown similar anti-fibrotic effects in ... scientists present novel data demonstrating anti-fibrotic effects ...
(Date:4/19/2017)... 2017 The Mobile X-Ray product segment is the ... during the forecast period Mobile X-Ray segment is ... mobile X-Ray devices market, which is estimated to be valued ... a CAGR of 7% over the forecast period. Mobile X-Ray ... than US$ 100 Mn in 2017 over 2016. The segment,s ...
Breaking Medicine Technology: